Agios Pharmaceuticals

Cambridge,  MA 
United States
  • Booth: 203

Agios is focused on discovering and developing novel medicines to treat cancer and rare genetic diseases through scientific leadership in cellular metabolism and adjacent areas of biology. In addition to an active research pipeline, Agios has two approved oncology medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development.

Questions or Need Assistance?


Technical support: Support

For more tips, visit the FAQ.

Featured Products
View All

Want your product featured here? Click to upgrade your online exhibitor listing.